This resource is intended for all clinicians, especially those providing pharmacological interventions for drug misusers as a component of drug misuse treatment. The report discusses the effectiveness of drug treatment, the impact of drug misuse on families and communities, psychosocial components of treatment, health considerations including preventing drug-related death and blood-borne infections and considered specific treatment situations and populations such as mental health, criminal justice, pregnancy, young people and prisons.
This report from the Social Justice Policy Group, chaired by Iain Duncan Smith, identifies five 'pathways' to poverty and makes proposals for tackling them. These pathways are: educational failure, family breakdown, economic dependence, indebtedness and addictions. A sixth section considers how the third sector might be better supported to help people escape poverty.
In this ground-breaking report, the Advisory Council on the Misuse of Drugs considers the impact on children of parental problem drug use. For the first time ever, it assesses the number of affected children in the UK.
It examines the evidence for significant harm to their health and well-being. It considers what is being done at present to help them and what more could be done.
Harm reduction has become one of the most contentious issues in drug use policy. The initial clarity and simplicity of the phrase "harm reduction" has evolved into an emotion-laden designation that has polarized groups with a common goal and is interfering with opportunities to engage high-risk populations and the implementation of a range of substance abuse services and supports.